These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9589685)

  • 1. Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome.
    Guido M; Pavone V; Ciampelli M; Murgia F; Fulghesu AM; Apa R; Caruso A; Mancuso S; Lanzone A
    J Clin Endocrinol Metab; 1998 May; 83(5):1742-5. PubMed ID: 9589685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: relationship with insulin and luteinizing hormone secretion.
    Lanzone A; Fulghesu AM; Cucinelli F; Ciampelli M; Caruso A; Mancuso S
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3501-6. PubMed ID: 8530590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients.
    Villa P; Fulghesu AM; De Marinis L; Valle D; Mancini A; Pavone V; Caruso A; Lanzone A
    Metabolism; 1997 May; 46(5):538-43. PubMed ID: 9160821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study.
    Fulghesu AM; Ciampelli M; Belosi C; Apa R; Guido M; Caruso A; Mancuso S; Lanzone A
    J Endocrinol Invest; 2001; 24(7):483-90. PubMed ID: 11508781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism.
    Villa P; Valle D; Mancini A; De Marinis L; Pavone V; Fulghesu AM; Mancuso S; Lanzone A
    Fertil Steril; 1999 Jan; 71(1):115-21. PubMed ID: 9935127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid blockade effect on insulin beta-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus.
    Ciampelli M; Fulghesu AM; Guido M; Murgia F; Muzj G; Belosi C; Fortini A; Cento R; Lanzone A
    Horm Res; 1998; 49(6):263-8. PubMed ID: 9623517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease.
    Fulghesu AM; Lanzone A; Cucinelli F; Caruso A; Mancuso S
    Obstet Gynecol; 1993 Aug; 82(2):191-7. PubMed ID: 8336863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease.
    Fulghesu AM; Lanzone A; Andreani CL; Pierro E; Caruso A; Mancuso S
    Fertil Steril; 1995 Oct; 64(4):703-8. PubMed ID: 7672138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome.
    Fulghesu AM; Villa P; Pavone V; Guido M; Apa R; Caruso A; Lanzone A; Rossodivita A; Mancuso S
    J Clin Endocrinol Metab; 1997 Feb; 82(2):644-8. PubMed ID: 9024269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of opioid blockade on insulin metabolism in polycystic ovarian disease.
    Fulghesu AM; Ciampelli M; Fortini A; Cucinelli F; Guido M; Caruso A; Lanzone A; Mancuso S
    Hum Reprod; 1995 Sep; 10(9):2253-7. PubMed ID: 8530646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential androgen response to adrenocorticotrophin hormone stimulation and effect of opioid antagonist on insulin secretion in polycystic ovarian syndrome.
    Lanzone A; Fulghesu AM; Guido M; Ciampelli M; Caruso A; Mancuso S
    Hum Reprod; 1994 Dec; 9(12):2242-6. PubMed ID: 7714138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens.
    Nestler JE; Jakubowicz DJ
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4075-9. PubMed ID: 9398716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine and metabolic effects of insulin sensitizers in the treatment of patients with polycystic ovary syndrome and hyperinsulinaemia.
    Ciotta L; De Leo V ; Farina M; Pafumi C; La Marca A ; Cianci A
    Gynecol Obstet Invest; 2001; 51(1):44-50. PubMed ID: 11150875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease.
    Fulghesu AM; Ciampelli M; Guido M; Murgia F; Caruso A; Mancuso S; Lanzone A
    Metabolism; 1998 Feb; 47(2):158-62. PubMed ID: 9472963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of opioid antagonists in the treatment of women with glucoregulation abnormalities.
    Guido M; Romualdi D; Lanzone A
    Curr Pharm Des; 2006; 12(8):1001-12. PubMed ID: 16533167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.
    Ehrmann DA; Cavaghan MK; Imperial J; Sturis J; Rosenfield RL; Polonsky KS
    J Clin Endocrinol Metab; 1997 Feb; 82(2):524-30. PubMed ID: 9024248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.
    Lanzone A; Fulghesu AM; Andreani CL; Apa R; Fortini A; Caruso A; Mancuso S
    Hum Reprod; 1990 Feb; 5(2):143-9. PubMed ID: 2108986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of relationship between 17-hydroxyprogesterone response to buserelin testing and hyperinsulinemia in polycystic ovary syndrome.
    Sahin Y; Ayata D; Keleştimur F
    Eur J Endocrinol; 1997 Apr; 136(4):410-5. PubMed ID: 9150702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone effects on insulin sensitivity and insulin secretion in hyperandrogenic women.
    Sir-Petermann T; López G; Castillo T; Calvillán M; Rabenbauer B; Wildt L
    Exp Clin Endocrinol Diabetes; 1998; 106(5):389-94. PubMed ID: 9831304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin and insulin-like growth factor-I responsiveness in polycystic ovarian syndrome.
    Buyalos RP; Geffner ME; Bersch N; Judd HL; Watanabe RM; Bergman RN; Golde DW
    Fertil Steril; 1992 Apr; 57(4):796-803. PubMed ID: 1555690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.